Who owns IMRX?
Institutional ownership of Immuneering Corporation from Form 13F, Q2 2026
112 institutional managers reported holding Immuneering Corporation (IMRX) in Form 13F filings for Q2 2026, with 34,451,908 shares worth $172M. The largest reported holder was FMR LLC. Managers that filed both quarters added a net 5,146,225 shares (+17.6%). 38 opened new positions and 21 sold out.
- Funds holding
- 112
- Value held
- $172M
- New / sold out
- 38 / 21
- Net shares, same filers
- +17.6%
Holdings as of June 30, 2026, the end of Q2 2026. Managers have 45 days after a quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
Largest holders of IMRX
| Fund | Value | Share of 13F holdings | Shares | Move |
|---|---|---|---|---|
| FMR LLC | $48.4M | 28.2% | 9,704,610 | Unchanged |
| BlackRock, Inc. | $21.8M | 12.7% | 4,374,020 | Added |
| Sanofi | $13.5M | 7.9% | 2,708,559 | Unchanged |
| Vanguard Capital Management LLC | $11.4M | 6.6% | 2,286,434 | Unchanged |
| Price T Rowe Associates Inc | $9.7M | 5.6% | 1,936,076 | Added |
| Geode Capital Management, LLC | $6.8M | 4.0% | 1,370,750 | Added |
| State Street Corp | $5.0M | 2.9% | 1,001,995 | Added |
| DCF Advisers, LLC | $3.9M | 2.3% | 790,000 | Added |
| Marshall Wace, LLP | $3.7M | 2.1% | 731,897 | Trimmed |
| Connor, Clark & Lunn Investment Management Ltd. | $3.0M | 1.7% | 601,255 | Added |
| Alethea Capital Management, LLC | $2.4M | 1.4% | 472,935 | Added |
| Summit Financial, LLC | $2.3M | 1.3% | 452,264 | Added |
| UBS Group AG | $2.2M | 1.3% | 448,857 | Added |
| Nuveen, LLC | $2.2M | 1.3% | 438,362 | New |
| Northern Trust Corp | $2.2M | 1.3% | 436,992 | Added |
| Levin Capital Strategies, L.p. | $2.1M | 1.2% | 414,000 | Added |
| Citadel Advisors LLC | $1.9M | 1.1% | 386,411 | Trimmed |
| Vanguard Fiduciary Trust Co | $1.8M | 1.0% | 360,764 | Added |
| Vanguard Portfolio Management LLC | $1.8M | 1.0% | 359,085 | New |
| Gsa Capital Partners LLP | $1.7M | 1.0% | 343,303 | Added |
| Millennium Management LLC | $1.6M | 1.0% | 330,402 | Trimmed |
| Burkehill Global Management, LP | $1.5M | 0.9% | 300,000 | Unchanged |
| Two Sigma Investments, LP | $1.4M | 0.8% | 288,420 | Added |
| Morgan Stanley | $1.1M | 0.7% | 226,491 | Trimmed |
| Occam Crest Management LP | $1.1M | 0.8% | 278,498 | Trimmed |
Share of 13F holdings is each fund's shares as a share of the 34,451,908 IMRX shares all 13F filers reported, not of shares outstanding.
Biggest buyers in Q2 2026
- BlackRock, Inc. Added+$14.3M
- State Street Corp Added+$3.7M
- Geode Capital Management, LLC Added+$3.7M
- DCF Advisers, LLC Added+$3.2M
- Alethea Capital Management, LLC Added+$2.2M
- Nuveen, LLC New+$2.2M
- Levin Capital Strategies, L.p. Added+$2.0M
- Vanguard Portfolio Management LLC New+$1.8M
- Northern Trust Corp Added+$1.6M
- Gsa Capital Partners LLP Added+$1.3M
Biggest sellers in Q2 2026
- Marshall Wace, LLP Trimmed-$6.3M
- Millennium Management LLC Trimmed-$3.9M
- Goldman Sachs Group Inc Trimmed-$1.2M
- Occam Crest Management LP Trimmed-$1.1M
- Diametric Capital, LP Sold out-$922K
- Squarepoint Ops LLC Trimmed-$840K
- Wellington Management Group LLP Sold out-$824K
- 683 Capital Management, LLC Sold out-$794K
- Barclays PLC Trimmed-$507K
- Hudson Bay Capital Management LP Sold out-$505K
The change in shares since the quarter before, adjusted for stock splits and priced at the Q2 2026 value per share. Funds bought $47.4M and sold $21.8M; 34 added and 19 trimmed.
Schedule 13D and 13G filings on IMRX
Owners of more than 5% must file within days, so these can be newer than the 13F data.
- 2026-07-28BlackRock, Inc. SCHEDULE 13G filed by BlackRock Inc.Schedule 13G
- 2025-10-21Empery Asset Management, LP SCHEDULE 13G filed by Immuneering CorporationSchedule 13G
- 2025-10-07FMR LLC SCHEDULE 13G filed by Immuneering CorporationSchedule 13G
- 2025-10-03HBM Healthcare Investments (Cayman) Ltd. SCHEDULE 13G filed by Immuneering CorporationSchedule 13G
Questions about IMRX ownership
- Who owns IMRX stock?
- 112 institutional investment managers reported IMRX positions in their Form 13F filings for Q2 2026, holding 34,451,908 shares worth $172M in total. FMR LLC reported the largest position.
- Are funds buying or selling IMRX?
- In Q2 2026, 38 managers opened new IMRX positions, 34 added, 19 trimmed and 21 sold out. Managers that filed in both quarters added a net 5,146,225 shares.
- How current is this IMRX institutional ownership data?
- It covers holdings as of the end of Q2 2026. Managers have 45 days after the quarter ends to file Form 13F (by August 14, 2026 for Q2 2026), so positions may have changed since.
From the SEC's Form 13F data sets for Q2 2026: every 13F holdings report, matched to IMRX by CUSIP. Options are left out. IMRX news and filings · IMRX insider trades · Top funds